eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2023
vol. 40
 
Share:
Share:
Original paper

NO-induced apoptosis in human melanocytes from lightly and darkly pigmented skin

Łukasz Marek
1
,
Irena Tam
1
,
Sławomir Kurkiewicz
1
,
Paulina Borkowska
2
,
Anna Dzierżęga-Lęcznar
1

  1. Department of Instrumental Analysis, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Poland
  2. Department of Medical Genetics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Poland
Adv Dermatol Allergol 2023; XL (2): 259-267
Online publish date: 2023/03/20
Article file
- NO-induced.pdf  [1.20 MB]
Get citation
 
 

Introduction

Apoptosis, one of the forms of programmed cell death, is fundamental for homeostasis of the skin. Physiologically, it enables the development and maintenance of normal thickness and structure of the epidermis. It also provides an important defence mechanism against neoplastic transformation that may be induced in the skin by various harmful stimuli [1, 2]. Unlike keratinocytes and other cell types residing in the epidermis, melanin-producing melanocytes are considered quite resistant to apoptosis [3]. In vitro studies show that normal melanocytes can enter the apoptotic pathway when exposed to dopamine [4], homocysteine [5], interferon-γ (INF-γ) [6], cytosolic poly (dA:dT) (an analogue of viral non-CpG ds DNA) [7], the synthetic tyrosine analogue 4-TBP (4-tert-butyl-phenol) [8], particulate matter 2.5 (PM 2.5) [9], and ultraviolet (UV) radiation [3]. Exposure of the skin to UVA and UVB radiation is a well-described factor that increases nitric oxide (NO) levels in the epidermis via activation of inducible nitric oxide synthase (iNOS) in keratinocytes, Langerhans cells and melanocytes [10].

As a messenger molecule that affects many various cell signalling pathways, NO is known to be involved in numerous physiological and pathological processes in target tissues, including vascular homeostasis or inflammatory and immune responses [11]. A large body of in vitro evidence demonstrates that NO is also a potent modulator of programmed cell death, with the ability to both induce and prevent apoptosis. The pro- or antiapoptotic effect appears to be cell-type specific, but it depends also on the NO concentration and its delivery method, exposure time, and possible interactions with other molecules present in the biological milieu, such as oxygen or superoxide anion, thiols or proteins, antioxidants, etc. [12, 13]. NO was reported to affect apoptosis in a wide variety of cells, including macrophages, neurons, pancreatic β-cells, thymocytes, chondrocytes, hepatocytes, endothelial cells, eosinophils, or B lymphocytes [13]. Very little is known about the possible modulatory effect of NO on programmed death of epidermal melanocytes, and these scarce data are mainly related to melanoma cells. For instance, overproduction of NO via induction of NOS was found to promote apoptosis in hypoxic murine melanoma models and human A375-S2 melanoma cells [14, 15]. On the other hand, it has been suggested that constitutive NO production prevents apoptosis and is therefore essential for the survival of human melanoma cells. Reduced levels of endogenous NO due to iNOS inhibition induced apoptosis in patient-derived melanoma cells, but interestingly not in normal human epidermal melanocytes [16]. Ivanova et al. [17, 18] described NO-induced detachment of human epidermal melanocytes from the extracellular matrix in vitro and suggested apoptotic cell death as a major part of the underlying mechanism. Interestingly, the cell response to NO was modified by the level of cell pigmentation. In light of recent studies [19, 20], the cell pigmentation phenotype appears to be an important factor modulating the biochemical behaviour of melanocytes in response to various intrinsic and extrinsic stimuli.

Aim

The present study aims to answer the question of whether NO is indeed able to induce apoptosis in normal human epidermal melanocytes and whether the pigmentation phenotype of the cells could be a factor modulating their response to NO in this respect.

Material and methods

Reagents and compounds

N-[4-[1-(3-Aminopropyl)-2-hydroxy-2-nitrosohydrazino]butyl]-1,3-propanediamine (spermine–nitric oxide complex; SPER/NO), Dulbecco’s Phosphate Buffered Saline (D-PBS), Hoechst 33342 fluorescent dye, and Trypan Blue solution (0.4%) were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA). Growth medium M-254 supplemented with Human Melanocyte Growth Supplement (HMGS), and antibiotic/antimycotic solution of gentamicin and amphotericin B were obtained from Cascade Biologics/GIBCO Life Technologies (Carlsbad, CA, USA).

Cell culture

Primary human epidermal melanocytes derived from the neonatal foreskin of lightly and darkly pigmented donors (HEMn-LP; Lot # 423339 and HEMn-DP; Lot # 765194) were cultured in the supplemented medium in a humidified atmosphere of 5% CO2 at 37°C. All experiments were performed using cells at passages 3-5. SPER/NO was dissolved directly in the culture medium immediately before use.

Analysis of cell morphology, proliferation, and viability

HEMn were seeded in complete medium and allowed to attach and grow for 48 h. Then, SPER/NO (50–500 μM) was added in a fresh medium, and the cells were incubated for 24 h. Morphological changes of HEMn after SPER/NO treatment were evaluated using a reversed-phase microscope. Cell proliferation was measured by 5-bromo-2′-deoxyuridine (BrdU) incorporation during DNA synthesis using Cell Proliferation ELISA BrdU assay (Roche, Basel, Switzerland) according to the manufacturer’s protocol. Determination of the number of viable cells was based on quantitation of ATP using the CellTiter-Glo®Luminescent Cell Viability Assay (Promega, Madison, WI, USA) according to the manufacturer’s protocol.

Detection of apoptosis by flow cytometry

Adherent melanocytes incubated with or without SPER/NO (100, 250, and 500 μM) for 24 h were harvested by trypsinization and pooled with the cells floating in the medium. The cells were double-stained with the CF488A-Annexin V and PI (propidium iodide) Apoptosis Assay Kit (Biotum, Fremont, CA, USA) following the manufacturer’s instructions, and then they were analysed by flow cytometry using a FACSAria II flow cytometer (BD, Franklin Lakes, NJ, USA). CF488A-Annexin V-positive/PI-negative cells were identified as early apoptotic, whereas CF488A-Annexin V-positive/PI-positive cells were classified as late apoptotic (secondary necrotic) cells.

Nuclear staining with Hoechst

The morphological changes in HEMn incubated with or without SPER/NO (50–500 μM) for 24 h were determined by DNA staining with Hoechst 33342 fluorescent dye and were visualized by AxioVert.A1FL inverted microscope with epi-fluorescence LED (Carl Zeiss Microscopy, NY, USA).

DNA fragmentation assay

HEMn were incubated with or without 500 μM SPER/NO for 24 h. Adherent and detached cells were then collected, and genomic DNA was extracted from the cells with the Apoptotic DNA Ladder Kit (Roche, Basel, Switzerland). The extracted DNA and the DNA ladder marker (Gene Ruler™ 1000 bp DNA Ladder, Thermo Scientific™) were loaded onto 1% agarose gel, and DNA fragments were separated by electrophoresis. The DNA ladder pattern was visualized on a UV transilluminator by SYBR®Green staining (Sigma-Aldrich, St. Louis, MO, USA). Images were obtained using a ChemiDOC™ XRS+Imaging System (Bio-Rad Laboratories, Hercules, CA, USA).

Caspase activity assay

Activities of caspases 3/7, 8, and 9 in cultured melanocytes incubated with or without SPER/NO (50–500 μM) for 24 h were measured using the Caspase-Glo®-3/7, -8, and -9 Assay kits (Promega, Madison, WI, USA) according to the manufacturer’s instructions. The luminescence intensity (RLU), proportional to the activity of caspase, was read in a TRIAD LT microplate reader (Dynex Technologies, Chantilly, VA, USA).

Gene expression analysis

Expression of the genes encoding B cell lymphoma 2 (BCL-2) protein and BCL-2-associated X protein (BAX) was analysed by real-time reverse transcription polymerase chain reaction (RT-PCR) technique. Total RNA was extracted from the cultured cells using the Direct-zolRNA MiniPrep Kit (Zymo Research, Irvine, CA, USA) according to the manufacturer’s protocol. RNA samples were treated with DNase I solution and additionally purified using the OneStepPCR Inhibitor Removal Kit (Zymo Research, Irvine, CA, USA). First-strand cDNA synthesis was performed with 1 μg of total RNA using the iScriptReverse Transcription Supermix (Bio-Rad Laboratories, Hercules, CA, USA) according to the manufacturer’s instructions. Expression of mRNA for BAX, BCL-2, and GAPDH was determined using the SsoAdvancedUniversal SYBR®Green Supermix with CFX Connect Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA). The reaction mixture contained 10 μl SsoAdvancedUniversal SYBR®Green Supermix (2×), 1 μl PrimePCR SYBR Green Assay (20x) for BAX (qHsaCED0037943), BCL-2 (qHsaCED0057245), and GAPDH (qHsaCED0038674), 0.5 μl template cDNA, and 8.5 μl nuclease-free water. The reaction conditions were as follows: denaturation at 95°C for 30 s, followed by 40 cycles at 95°C for 5 s and 60°C for 30 s. Each sample was run in triplicate, and threshold cycle (Ct) values were collected. BCL-2 and BAX mRNA levels were normalized to GAPDH. Fold change in expression of BCL-2 and BAX was calculated by the 2–ΔΔCt method.

Statistical analysis

Data were analysed with one-way analysis of variance (ANOVA) (Statistica 13.3 software; StatSoft Inc., Tulsa, OK). The values from 3 separate experiments were combined to obtain the mean and standard error of the mean (SEM). Statistical significance was established as p < 0.05.

Results

Nitric oxide induces cell morphological changes and reduces melanocyte proliferation and viability

As shown in Figures 1 and 2, the exposure of melanocytes to NO released from SPER/NO that was added to the culture medium at relatively low concentrations (50 and 100 μM) had no effect on cell morphology, proliferation, and viability. However, the presence of 250 and 500 μM SPER/NO in the culture medium led to dendrite retraction, cell rounding, and cell detachment from the monolayer. In addition, a significant reduction or even complete inhibition of cell proliferation, as well as significant decrease in cell viability, were observed.

Figure 1

Morphological changes observed in HEMn treated with various concentrations of SPER/NO (50–500 μM) and cultured for 24 h under an inverted microscope (magnification: ×200). The arrows indicate detached cells

/f/fulltexts/PDIA/50362/PDIA-40-50362-g001_min.jpg
Figure 2

HEMn were treated with various concentrations of SPER/NO (50–500 μM) and cultured for 24 h. A – Cell proliferation was assessed using Cell Proliferation ELISA BrdU (Roche, Basel, Switzerland). B – Cell viability was determined by measuring intracellular ATP levels using CellTiter-Glo®Luminescent Cell Viability Assay (Promega, Madison, WI, USA). Values express as percentage of control, and represent the mean ± SEM of 3 independent experiments; *p < 0.05 versus untreated control (melanocytes cultured without SPER/NO), #p < 0.05 between HEMn-LP and HEMn-DP

/f/fulltexts/PDIA/50362/PDIA-40-50362-g002_min.jpg

Nitric oxide induces apoptosis in melanocytes

The results of Annexin V/PI flow cytometry (Figure 3) demonstrated significantly enhanced apoptosis only in HEMn exposed to the highest SPER/NO concentration used. HEMn-LP were more prone to NO-induced apoptosis than HEMn-DP. After the exposure to 500 μM SPER/NO, the total percentages of apoptotic LP and DP melanocytes were assessed as 95% and 18%, respectively. Hoechst 33342 staining showed that HEMn treatment with 250 and 500 μM SPER/NO induced cell shrinkage, chromatin condensation, and nucleus fragmentation (Figure 4, upper panel). At 500 μM SPER/NO, DNA cleavage into oligonucleosomal-sized fragments was also observed (Figure 4, lower panel).

Figure 3

Representative cytometric analyses of apoptotic melanocytes (upper panel), and percentage of apoptotic cells (lower panel). HEMn-LP and HEMn-DP were exposed to various concentrations of SPER/NO for 24 h. Then, the cells were double-stained with CF488A-Annexin V and propidium iodide, and analysed by flow cytometry. Images display the distribution of viable cells (lower left quadrant), early apoptotic cells (lower right quadrant), late apoptotic cells (upper right quadrant), and necrotic cells (upper left quadrant) expressed as a percentage

/f/fulltexts/PDIA/50362/PDIA-40-50362-g003_min.jpg
Figure 4

Cell apoptosis observed using Hoechst 33342 staining and DNA fragmentation. The morphology of HEMn-LP and HEMn-DP nuclei grown for 24 h without (control) and with 250 and 500 μM SPER/NO revealed by fluorescence microscopic detection (magnification: ×400). Chromatin condensation and nucleus fragmentation are indicated by arrows (upper panel). DNA fragmentation in HEMn-LP (lane 1) and HEMn-DP (lane 3) treated with 500 μM SPER/NO for 24 h. Lanes 2 and 4 – untreated HEMn-LP and HEMn-DP, respectively; lane 5 – positive control (apoptotic U937 cells); lane 6 – DNA ladder marker (lower panel)

/f/fulltexts/PDIA/50362/PDIA-40-50362-g004_min.jpg

Culturing of HEMn in the presence of 250 and 500 μM SPER/NO led to the significant activation of caspases 9 and 3/7 (Figure 5). The highest concentration used caused a nearly 3-fold increase in caspase 9 activity in both HEMn types. Under the same conditions, caspase 3/7 activity increased 6-fold in HEMn-DP and as much as 14-fold in HEMn-LP, as compared to the untreated control cells. Relatively low activity of caspase 8 was slightly elevated only in the melanocytes growing with 500 μM SPER/NO.

Figure 5

Caspase activation by nitric oxide in HEMn-LP and HEMn-DP. Melanocytes were treated with indicated SPER/NO concentrations (50–500 μM) and cultured for 24 h. Activities of caspase 9, caspase 3/7, and caspase 8 were determined as described in Material and methods. Data are the mean ± SEM of at least 3 independent experiments; *p < 0.05 vs. untreated control, #p < 0.05 between HEMn-LP and HEMn-DP

/f/fulltexts/PDIA/50362/PDIA-40-50362-g005_min.jpg

Nitric oxide affects BCL-2 and BAX expression

As shown in Figure 6, SPER/NO treatment had no effect on BAX expression in HEMn-LP. In HEMn-DP, the exposure to NO donor increased the BAX mRNA level (3-fold compared to the control) only at 500 μM. Up to 250 μM, SPER/NO had no significant effect on BCL-2 expression in both types of HEMn, whereas exposure of cells to the highest concentration of the NO donor (500 μM) led to a 1.5-fold and 6.5-fold increase in BCL-2 expression in HEMn-LP and HEMn-DP, respectively.

Figure 6

Relative BAX and BCL-2 mRNA expression levels in HEMn-LP and HEMn-DP treated with various SPER/NO concentrations (50–500 μM) for 12 h. The mRNA transcript levels of BAX and BCL-2 gene were measured by real-time reverse transcription-polymerase chain reaction. Fold changes in BAX and BCL-2 mRNA expression levels were calculated relative to the untreated control cultures

/f/fulltexts/PDIA/50362/PDIA-40-50362-g006_min.jpg

In general, DP melanocytes cultured with 0-250 μM SPER/NO showed 2-fold higher expression of BAX and BCL-2 than LP melanocytes grown under the same conditions (Table 1). The difference in the apoptotic gene expression between the cells was even more pronounced at the highest concentration of the NO donor. In this case, BAX and BCL-2 mRNA levels in HEMn-DP were 3-fold and 5-fold higher than in HEMn-LP, respectively.

Table 1

Fold changes in BAX and BCL-2 mRNA expression levels refer to the comparison of HEMn-DP with HEMn-LP. Data represent the mean ± SEM (n = 3)

SPER/NO [μM]Relative mRNA expression (HEMn-DP vs. HEMn-LP)
BAXBCL-2
01.6 ±0.11.9 ±0.02
502.1 ±0.032.5 ±0.23
1002.0 ±0.242.4 ±0.35
2501.6 ±0.181.7 ±0.06
5002.9 ±0.174.6 ±0.25

Discussion

Our results demonstrate that NO is capable of inducing apoptosis in normal human epidermal melanocytes. The cell response to NO depends on its concentration in the culture medium and seems to be modulated by the pigmentation phenotype of the cells. As a source of NO we used SPER/NO, which spontaneously decomposes when added to the culture medium, liberating 2 moles of NO per mole of the parent molecule [21, 22]. Such a method of delivering NO to the culture system mimics to some extent the pathophysiological processes in the skin, where melanocytes are stimulated in an autocrine or paracrine manner by extracellular NO.

Microscope assessment of HEMn growing in the SPER/NO-supplemented media suggested that NO at high concentrations was toxic to the cultured cells. When the cells were cultured in the presence of 250 and 500 μM SPER/NO, we observed changes in cell shape and loss of adherence. Our preliminary conclusion about NO toxicity towards HEMn was confirmed by the results of the cell proliferation and viability assays. After exposure to 250 μM SPER/NO, the number of actively proliferating HEMn-DP in relation to the matched control was significantly lower than that estimated for HEMn-LP. Doubling the concentration of the NO donor almost completely blocked HEMn proliferation and markedly reduced relative cell viability. Interestingly, the viability of HEMn-DP treated with 500 μM SPER/NO was significantly higher than HEMn-LP cultured under the same conditions. Although the cell viability assay used here, based on measuring of total cellular ATP levels, does not distinguish between cytotoxic and cytostatic effects, the cell detachment from the monolayer suggested cell death as a result of NO treatment. Indeed, we found that NO released from SPER/NO induced cell shrinkage, chromatin condensation, nuclear fragmentation, and degradation of genomic DNA in cultured HEMn-LP and HEMn-DP, which are the morphological and biochemical hallmarks of apoptosis. As shown by flow cytometric analysis, the presence of NO in the culture medium increased the percentage of apoptotic HEMn compared with the untreated controls, especially at the highest concentration of the NO donor, where the increase was found to be significant. HEMn from darkly pigmented skin were much more resistant to apoptotic death than those from lightly pigmented skin. At 500 μM SPER/NO, almost all of HEMn-LP in culture were at the stage of early or late apoptosis, whereas the percentage of apoptotic HEMn-DP was significantly lower.

Significantly elevated caspase 9 activities compared to the controls indicates that NO exposure primarily activates the intrinsic (mitochondrial) apoptosis pathway in the cultured HEMn. Again, the cell response was found to be associated with the pigmentation phenotype. Interestingly, although HEMn-DP responded more strongly than HEMn-LP in this regard, the activation of the effector caspase 3/7 under high concentrations of NO was proportionally weaker in HEMn-DP than in HEMn-LP. The activation of the intrinsic pathway of apoptosis was described earlier for human foreskin melanocytes exposed to UV radiation [23]. Our results show that, at high concentrations, NO can also activate the extrinsic (death receptor) apoptotic pathway in HEMn, as indicated by slightly increased caspase 8 activity in the cells cultured in the presence of 500 μM SPER/NO. It should be noted, however, that caspase 8 can also be activated by caspase 9 via caspases 7 and 6 [24]. A key role in the regulation of the intracellular apoptosis pathway is played by proteins of the Bcl-2 family, which includes proteins that both inhibit (Bcl-2, Bcl-xL) and/or initiate cell apoptosis (Bax, Bcl-xS, Bak, Bik, Bim, Bad, Bid) [25]. We found that NO exposure did not affect the mRNA expression of either BAX or BCL-2 in cultured HEMn-LP, even at the highest concentration of the NO donor that led to the significantly enhanced expression of both the genes in HEMn-DP. Importantly, the relative expression of antiapoptotic BCL-2 in HEMn-DP versus control increased almost 7 fold, whereas proapoptotic BAX only 3 fold. This could explain why HEMn-DP are more resistant than HEMn-LP to apoptosis induced by high concentrations of NO in the culture medium. Some studies on macrophages show that BCL-2 overexpression may be protective against NO-induced cytotoxicity. BCL-2 has been found to interfere upstream of caspases, i.e. caspase-3 activation, and therefore acts as an effective signal terminator during NO-induced apoptosis [26]. Dhakshinamoorthy et al. [27] indicated that BCL-2 successfully counteracts NO-induced death of neuroblastoma cells. Kim et al. [28] reported that a high constitutive level of BCL-2 protein can protect melanocytes from damage caused by UVB radiation. Bivik et al. [29] showed that after UVB exposure melanocytes up-regulated BCL-2 at the mRNA level without showing any change at the protein level. Our results are in line with these and other findings, which underscore an important role for the BCL-2 protooncogene and its protein product in the cell resistance to NO-induced apoptosis [3032].

The results of the present study suggest that the pigmentation phenotype may be an important modulating factor responsible for the different response of human epidermal melanocytes to proapoptotic activity of extracellular NO. The commercially available cells we used here were derived from the donors of various degree of constitutive skin pigmentation. A previous study revealed that HEMn-DP contains almost twice as much melanin as HEMn-LP [33]. Stępień et al. [34] demonstrated in vitro that melanin can act as an effective scavenger of peroxynitrite, a highly reactive molecule that is readily formed from NO under oxidative stress conditions. It seems likely that intracellular melanin can also act as a natural scavenger of reactive nitrogen species. This could go some way to explaining why HEMn-DP are more resistant to the cytotoxic effects of NO released from SPER/NO and why apoptosis is less intense in these cells compared to HEMn-LP. Numerous studies have shown that there is a relationship between the effect of various cytotoxic agents and the degree of melanocyte pigmentation [3540]. It was also shown that the cell pigmentation phenotype modulates the inflammation-induced expression of numerous genes encoding cytokines and chemokines in human epidermal melanocytes in culture. The proinflammatory response of HEMn-LP was generally more pronounced than that of HEMnDP [19]. On the other hand, the genetic background of a given melanocyte phenotype could also be involved in the cell response to various stimuli, including NO. Genome-wide transcriptome analysis revealed differences between melanocytes from dark and light skin in basal expression levels of some genes important for melanocyte development and functions [19, 41].

We believe that the results of our study may contribute to a better understanding of skin pathology, including vitiligo. Although the pathogenesis of melanocyte destruction characteristic of this depigmentation disorder is still under investigation, apoptosis is listed as one of the cell death modalities [42]. Our study suggests that NO, the level of which is known to be elevated in vitiligo lesions as a result of overexpression of NOS [43], could trigger epidermal melanocytes to undergo apoptosis, and that the cell response could be modulated to a great extent by the pigmentation phenotype.

Acknowledgments

This work was financially supported by the Medical University of Silesia in Katowice, Poland (Grants No. KNW-2-O02/N/6/N and KNW-1-089/K/7/0).

Conflict of interest

The authors declare no conflict of interest.

References

1 

Pustisek N, Situm M. UV-radiation, apoptosis and skin. Coll Antropol 2011; 35 Suppl 2: 339-41.

2 

Costanzo A, Fausti F, Spallone G, et al. Programmed cell death in the skin. Int J Dev Biol 2015; 59: 73-8.

3 

Bivik CA, Larsson PK, Kågedal KM, et al. UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members. J Invest Dermatol 2006; 126: 1119-27.

4 

Chu CY, Liu YL, Chiu HC, Jee SH. Dopamine-induced apoptosis in human melanocytes involves generation of reactive oxygen species. Br J Dermatol 2006; 154: 1071-9.

5 

Chen J, Zhuang T, Chen J, et al. Homocysteine induces melanocytes apoptosis via PERK-eIF2α-CHOP pathway in vitiligo. Clin Sci 2020; 134: 1127-41.

6 

Su Q, Wang F, Dong Z, et al. IFN-γ induces apoptosis in human melanocytes by activating the JAK1/STAT1 signaling pathway. Mol Med Rep 2020; 22: 3111-6.

7 

Wang S, Liu D, Ning W, Xu A. Cytosolic dsDNA triggers apoptosis and pro-inflammatory cytokine production in normal human melanocytes. Exp Dermatol 2015; 24: 298-300.

8 

Yang F, Sarangarajan R, Le Poole IC, et al. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol 2000; 114: 157-64.

9 

Suo D, Zeng S, Zhang J, et al. PM2.5 induces apoptosis, oxidative stress injury and melanin metabolic disorder in human melanocytes. Exp Ther Med 2020; 19: 3227-38.

10 

Tsatmali M, Graham A, Szatkowski D, et al. alpha-melanocyte-stimulating hormone modulates nitric oxide production in melanocytes. J Invest Dermatol 2000; 114: 520-6.

11 

Tuteja N, Chandra M, Tuteja R, Misra MK. Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology. J Biomed Biotechnol 2004; 2004: 227-37.

12 

Choi BM, Pae HO, Jang SIl, et al. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 2002; 35: 116-26.

13 

Li CQ, Wogan GN. Nitric oxide as a modulator of apoptosis. Cancer Lett 2005; 226: 1-15.

14 

Tendler DS, Bao C, Wang T, et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res 2001; 61: 3682-8.

15 

Yang J, Wu LJ, Tashiro S, et al. Nitric oxide activated by p38 and NF-kappaB facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells. Free Radic Res 2008; 42: 1-11.

16 

Salvucci O, Carsana M, Bersani I, et al. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 2001; 61: 318-26.

17 

Ivanova K, Le Poole IC, Gerzer R, et al. Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components. J Pathol 1997; 183: 469-76.

18 

Ivanova K, van den Wijngaard R, Gerzer R, et al. Non-lesional vitiliginous melanocytes are not characterized by an increased proneness to nitric oxide-induced apoptosis. Exp Dermatol 2005; 14: 445-53.

19 

Tam I, Dzierżęga-Lęcznar A, Stępień K. Differential expression of inflammatory cytokines and chemokines in lipopolysaccharide-stimulated melanocytes from lightly and darkly pigmented skin. Exp Dermatol 2019; 28: 551-60.

20 

Marek Ł, Tam I, Kurkiewicz S, Dzierżęga-Lęcznar A. The pigmentation phenotype of melanocytes affects their response to nitric oxide in vitro. Adv Dermatol Allergol 2023; 40: 150-8.

21 

Keefer LK, Nims RW, Davies KM, Wink DA. “NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms. Methods Enzymol 1996; 268: 281-93.

22 

Wanstall JC, Homer KL, Doggrell SA. Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr Vasc Pharmacol 2005; 3: 41-53.

23 

Wäster PK, Ollinger KM. Redox-dependent translocation of p53 to mitochondria or nucleus in human melanocytes after UVA- and UVB-induced apoptosis. J Invest Dermatol 2009; 129: 1769-81.

24 

Inoue S, Browne G, Melino G, Cohen GM. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 2009; 16: 1053-61.

25 

Kale J, Osterlund EJ, Andrews DW. BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ 2018; 25: 65-80.

26 

Brüne B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998; 351: 261-72.

27 

Dhakshinamoorthy S, Sridharan SR, Li L, et al. Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. Nucleic Acids Res 2007; 35: 5439-51.

28 

Kim YG, Kim HJ, Kim DS, et al. Up-Regulation and redistribution of Bax in ultraviolet B-irradiated melanocytes. Pigment Cell Res 2000; 13: 352-7.

29 

Bivik CA, Andersson EB, Rosdahl IK. Wavelength-specific effects on UVB-induced apoptosis in melanocytes. A study of Bcl-2/Bax expression and keratinocyte rescue effects. Melanoma Res 2005; 15: 7-13.

30 

Ciani E, Guidi S, Bartesaghi R. Contestabile A. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem 2002; 82: 1282-9.

31 

Kitamura Y, Kamoshima W, Shimohama S, et al. Nitric oxide donor-induced p53-sensitive cell death is enhanced by Bcl-2 reduction in human neuroblastoma cells. Neurochem Int 1998; 32: 93-102.

32 

Melkova Z, Lee SB, Rodriguez D, Esteban M. Bcl-2 prevents nitric oxide-mediated apoptosis and poly(ADP-ribose) polymerase cleavage. FEBS Lett 1997; 403: 273-8.

33 

Dzierżęga-Lęcznar A, Kurkiewicz S, Tam I, et al. Pheomelanin content of cultured human melanocytes from lightly and darkly pigmented skin: a pyrolysis-gas chromatography/tandem mass spectrometry study. J Anal Appl Pyrolysis 2017; 124: 349-54.

34 

Stępień K, Wilczok A, Zajdel A, et al. Peroxynitrite mediated linoleic acid oxidation and tyrosine nitration in the presence of synthetic neuromelanins. Acta Biochim Pol 2000; 47: 931-40.

35 

Barker D, Dixon K, Medrano EE, et al. Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B irradiation. Cancer Res 1995; 55: 4041-6.

36 

Yohn JJ, Lyons MB, Norris DA. Cultured human melanocytes from black and white donors have different sunlight and ultraviolet A radiation sensitivities. J Invest Dermatol 1992; 99: 454-9.

37 

Kobayashi N, Muramatsu T, Yamashina Y, et al. Melanin reduces ultraviolet-induced DNA damage formation and killing rate in cultured human melanoma cells. J Invest Dermatol 1993; 101: 685-9.

38 

Sparsa A, Bellaton S, Naves T, et al. Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines. Oncol Rep 2013; 29: 1196-200.

39 

Hauser JE, Kadekaro AL, Kavanagh RJ, et al. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res 2006; 19: 303-14.

40 

Shang J, Eberle J, Geilen CC, et al. The role of nuclear factor-kappa B and melanogenesis in tumor necrosis factor-alpha-induced apoptosis of normal human melanocytes. Skin Pharmacol Appl Skin Physiol 2002; 15: 321-9.

41 

Haltaufderhyde KD, Oancea E. Genome-wide transcriptome analysis of human epidermal melanocytes. Genomics 2014; 104: 482-9.

42 

Lu W, Zhao Y, Kong Y, et al. Geniposide prevents H2O2-induced oxidative damage in melanocytes by activating the PI3K-Akt signalling pathway. Clin Exp Dermatol 2018; 43: 667-74.

43 

Vaccaro M, Irrera N, Cutroneo G, et al. Differential expression of nitric oxide synthase isoforms nNOS and iNOS in patients with non-segmental generalized vitiligo. Int J Mol Sci 2017; 18: pii: E2533.

Copyright: © 2023 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.